SCFAs produced by anaerobic gut microbial fermentation of dietary fibre-rich substrates may act as epigenetic mechanisms in regulating IBD-related inflammation through inhibiting cytokine production (e.g., IL-17), which plays a key role in the pathogenesis of IBD [76]. This evidence concerns the gene IL17A and inflammatory bowel disease.